Skip to search formSkip to main contentSkip to account menu

Azilect

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Introduction: Parkinson‟s disease (PD) is characterized by a chronic progressive loss of nigrostriatal dopaminergic neurons that… 
Highly Cited
2015
Highly Cited
2015
IMPORTANCE Depression, cognitive impairment, and other nonmotor symptoms (NMSs) are common early in Parkinson disease (PD) and… 
2012
2012
This is a case report of a 69-year-old female with Parkinson's disease who developed an asymptomatic eruption on her legs… 
2012
2012
KEY POINTS Rasagiline, like selegiline, is an irreversible monoamine oxidase type-B (MAO-B) inhibitor It inhibits the breakdown… 
2010
2010
Increasing evidence suggests that oxidative stress (OS)-induced pancreatic β-cell impairments is involved in diabetes and… 
Highly Cited
2009
Highly Cited
2009
Novel therapeutic approaches for the treatment of neurodegenerative disorders comprise drug candidates designed specifically to… 
2008
2008
We recently reported that propargylamine derivatives such as rasagiline (Azilect) and its S-isomer TVP1022 are neuroprotective… 
Review
2006
Review
2006
  • M. Youdim
  • Current Alzheimer research
  • 2006
  • Corpus ID: 8838893
The therapeutic use of enzyme inhibitors in treatment of neurodegenerative diseases has its origin in the anti Parkinson action…